November 08, 2025 a 04:38 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. stands as a pioneer in the realm of minimally invasive surgical systems, offering advanced robotic technologies to enhance surgical precision. The company’s constant innovation, particularly with its da Vinci Surgical System, positions it favorably in the healthcare sector. Recent analyst ratings suggest cautious optimism with a predominant inclination towards holding the stock while recognizing its underlying growth potential amidst market fluctuations.
Historical Stock Grades
The latest analyst ratings for Intuitive Surgical show a continued preference for maintaining positions, with a notable concentration on Buy and Strong Buy ratings, indicating a positive sentiment overall despite a stable approach to holdings.
| Recommendation | Count | Score Visualization |
|---|---|---|
| Strong Buy | 7 | |
| Buy | 15 | |
| Hold | 10 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
Over the past months, Intuitive Surgical's analyst ratings have exhibited minimal fluctuations, with a consistent number of Strong Buy and Buy recommendations. However, there's a gradual increase in Hold ratings suggesting some cautiousness in market sentiment:
- Strong Buy ratings have remained stable over recent months, indicating sustained confidence in the company's potential.
- Buy ratings have also been consistent, revealing continued positive sentiment among analysts.
- A noticeable increase in Hold ratings over the past months suggests a more conservative outlook given market conditions.
Percentage Trends
This segment explores the percentage distribution of analyst recommendations over the recent months, highlighting any observable shifts in market sentiment:
- Strong Buy recommendations have reduced slightly from earlier highs but remain a strong influence, accounting for about 22-23% recently.
- The percentage of Buy recommendations dominates, comprising around 50-52%, illustrating prevailing optimism.
- An increase in Hold percentages, rising to almost 30%, indicates a growing sense of prudence among analysts.
- Sell and Strong Sell recommendations remain minimal, representing less than 5% altogether.
Latest Analyst Recommendations
The recent analyst activities have largely involved maintaining existing stances, reflecting stability in sentiment toward ISRG:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-23 | Neutral | Neutral | UBS |
| 2025-10-22 | Outperform | Outperform | RBC Capital |
| 2025-10-22 | Buy | Buy | Truist Securities |
| 2025-10-22 | Outperform | Outperform | Raymond James |
| 2025-10-22 | Overweight | Overweight | Wells Fargo |
Analyst Recommendations with Change of Opinion
Some analysts have revised their positions over recent years, which can indicate a re-evaluation of market conditions and company performance:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-09 | Sell | Hold | Deutsche Bank |
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
| 2024-11-19 | Buy | Hold | Erste Group |
| 2024-08-02 | Buy | Neutral | Redburn Atlantic |
| 2022-02-02 | Buy | Neutral | UBS |
Interpretation
The general stability in analyst recommendations for Intuitive Surgical, Inc. suggests a confidence in its market positioning and growth trajectory. With consistent Buy and Strong Buy sentiments, combined with a stable percentage of Hold ratings, the market perceives Intuitive Surgical as a reliable entity in the healthcare industry. However, the increased prudence in issuing Hold ratings could point to external market uncertainties. The minimal presence of Sell ratings, along with sustained Buy interest, underscores confidence in the company's long-term prospects.
Conclusion
Intuitive Surgical, Inc. maintains a strong foothold in the market as evidenced by stable and predominantly positive analyst ratings. Consistent Buy and Strong Buy recommendations highlight confidence in its innovative technological solutions in the surgical robotics field. Despite a slight increase in more conservative Hold ratings, the investment sentiment remains favorably optimistic. This assessment reflects both a recognition of the company’s robust market presence and a cautious approach to potential market fluctuations, emphasizing the importance of continued innovation and strategic management.